Anti-Cancer Drug Discovery: Structure, Function and Novel Strategy - Part-II
Thakur, S.S.
Current Topics in Medicinal Chemistry 19(17): 1490
2019
ISSN/ISBN: 1568-0266 PMID: 31592751 Document Number: 698379
Document emailed within 1 workday
Related Documents
Thakur, S.S. 2018: Anti-Cancer Drug Discovery: Structure, Function and Novel Strategy - (Part-I) Current Topics in Medicinal Chemistry 18(30): 2543O'Hanlon, K. 1999: Applied proteomics--analyzing protein structure and function for drug discovery. 27-28 January 1999, London, UK IDrugs: the investigational drugs journal 2(4): 299-300
Wong, J.Ho.; Sze, S.Cho.Wing.; Ng, T.Bun.; Cheung, R.Chi.Fai.; Tam, C.; Zhang, K.Yanbo.; Dan, X.; Chan, Y.Sang.; Shing Cho, W.Chi.; Ng, C.Cheuk.Wing.; Waye, M.Miu.Yee.; Liang, W.; Zhang, J.; Yang, J.; Ye, X.; Lin, J.; Ye, X.; Wang, H.; Liu, F.; Chan, D.Wai.; Ngan, H.Yuen.Sheung.; Sha, O.; Li, G.; Tse, R.; Tse, T.Fu.; Chan, H. 2018: Apoptosis and Anti-cancer Drug Discovery: The Power of Medicinal Fungi and Plants Current Medicinal Chemistry 25(40): 5613-5630
Pirhadi, S.; Shiri, F.; Ghasemi, J.B. 2013: Methods and applications of structure based pharmacophores in drug discovery Current Topics in Medicinal Chemistry 13(9): 1036-1047
Gupta, A.K. 2018: Current Advances in Computational Approaches for Drug Discovery- Part II Current Topics in Medicinal Chemistry 18(27): 2267
Cushion, M.T.; Walzer, P.D. 2009: Preclinical drug discovery for new anti-pneumocystis compounds Current Medicinal Chemistry 16(20): 2514-2530
Kojima, H.; Okabe, T.; Nagano, T. 2013: Open innovation center for drug discovery: a research-supporting network for drug discovery Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 141(6): 327-332
Ajaiyeoba, E.O.; Ogbole, O.O. 2006: A phytotherapeutic approach to Nigerian anti-HIV and immunomodulatory drug discovery African Journal of Medicine and Medical Sciences 35 Suppl: 71-76
Fujita, Y. 2013: Innovation by TaNeDS (Take a New challenge of Drug diScovery) collaborative drug discovery project Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 142(2): 89-95
Wunder, A.; Thiele, A.; Koslowski, M.; Gantner, F.; Niessen, H. 2014: Nuclear imaging to support anti-inflammatory drug discovery and development Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 2014
Shima, T.; Suwabe, K.; Soya, H. 2016: Effects of exercise on cognitive function: the possible strategy for anti-aging Nihon Rinsho. Japanese Journal of Clinical Medicine 74(9): 1577-1582
Bissinger, R.L. 1995: Renal physiology Part 1: Structure and function Neonatal Network: Nn 14(4): 9-20
Shen, Y. 2007: Discovery on Target 2007--CHI's Fifth Annual Conference. RNAi for Drug Discovery and Therapeutics IDrugs: the investigational drugs journal 10(12): 848-850
Young, S.S. 1999: Discovery 99: accelerate and improve the drug discovery process. 26-29 April 1999, San Diego, CA, USA IDrugs: the investigational drugs journal 2(7): 648-649
Reed, C. 2011: The changing face of eye banking. Part one: structure and function Insight 36(1): 26-27
Zhao, H.; Wang, Y.; Li, H. 2015: Cancer drug discovery targeting histone methyltransferases: an update Current Medicinal Chemistry 22(17): 2075-2086
Beggs, W.H. 1993: Anti-Candida activity of the anti-cancer drug tamoxifen Research Communications in Chemical Pathology and Pharmacology 80(1): 125-128
Hegazy, S.K.; El-Azab, G.A.; Zakaria, F.; Mostafa, M.F.; El-Ghoneimy, R.A. 2022: Mebendazole; from an anti-parasitic drug to a promising candidate for drug repurposing in colorectal cancer Life Sciences 299: 120536
Mager, P.P. 1975: MASCA-model of the biochemical-pharmacological drug research / part 5: Structure-activity relationships and MACOVA Arzneimittel-Forschung 25(11): 1745
Mager, P.P. 1975: MASCA-model of the biochemical-pharmacological drug research. Part 3: Structure-activity relationships and KANORA Arzneimittel-Forschung 25(9): 1355-1356